European Journal of Geriatrics and Gerontology

About European Journal of Geriatrics and Gerontology

European Journal of Geriatrics and Gerontology — Journal Profile

The European Journal of Geriatrics and Gerontology (EJGG) is the open access journal of the Turkish Academic Geriatrics Society, published from Türkiye by Galenos Publishing House. Founded in April 2019, it publishes clinical and basic science on ageing — frailty, sarcopenia, falls, dementia, polypharmacy, orthogeriatrics, palliative care and the whole map of geriatric syndromes — three times a year, in April, August and December, in electronic form and in English. Its single identifier is the electronic ISSN 2687-2625, the ISSN carried on this JournalsWorld record, printed on the journal's own site, and confirmed in the OpenAlex source record resolved from that ISSN. The journal's stated mission is to provide practical, timely and relevant clinical and basic science information to physicians and researchers practising geriatrics and gerontology worldwide — and despite the European in its title and the Turkish society behind it, its authorship and readership are genuinely international, with contributions in recent issues from Türkiye, the United States, China, Iran, Brazil and Denmark among others.

History and identity

EJGG is a young journal, and its youth is part of its story. The journal site dates its foundation to April 2019 — the same year its coverage begins in every database — created as the international, English-language journal of the Turkish Academic Geriatrics Society at a moment when geriatrics in Türkiye was marking its own maturity: the journal's pages carried, in its first year, a study of public awareness of geriatrics in the fiftieth year of geriatrics in Türkiye, which found awareness of the specialty among older people strikingly low and argued that government, health workers and community had to raise it together. A national society journal with an international name is a deliberate statement: the society wanted its clinicians' and researchers' work — on a population ageing as fast as any in Europe — to be written, reviewed and read in the field's shared language, and it built the journal accordingly, with Galenos, one of Türkiye's established medical publishers, as its publishing house.

The growth since 2019 has been steady and visible. OpenAlex's record for the journal counts 234 works through 2025, all of them open access, and the journal site's current-issue pages show a full research programme running at volume 8 in 2026, with an ahead-of-print stream feeding the three annual issues. The journal has also built the full policy apparatus of a modern medical title — separate pages on peer review, research ethics, authorship, conflicts of interest, data availability, artificial intelligence in manuscripts, appeals and complaints, archiving and preservation — which tells an author in advance exactly what regime a submission enters. For a journal founded in 2019, holding a Clarivate impact factor and a Scopus CiteScore on its own masthead, as EJGG now does, is the expected trajectory of a society title that has passed from launch to establishment.

Scope and subjects

The journal's aims and scope page lists one of the widest subject maps in geriatric publishing, and the list is worth reading as the field's own self-portrait. It names ageing and the biology of ageing; Alzheimer's disease and the cognitive disorders; biogerontology and cell biology; bone health in older people; clinical geriatrics and clinical geropsychology; delirium; diabetes; disability; drugs and ageing; the economics of ageing; falls; frailty; geriatric bioscience; and then a long run of geriatric subspecialty headings — care management, depression, emergency medicine, gynecology, occupational therapy, ophthalmology, otolaryngology, pain management, palliative care, pharmacotherapy, physical therapy, psychiatry, psychology, rheumatology, trauma, urology, nursing and the geriatric syndromes. It continues with gerontechnology, hypertension, healthy ageing, home and community-based services, incontinence, long-term care, orthogeriatrics, polypharmacy, Parkinson's disease and the parkinsonian syndromes, pressure sores, psychological and social gerontology, sarcopenia, sleep disorders, stroke medicine and syncope. Demography of older populations and dental and oral health in old age complete the map. A manuscript on almost any question that begins with an older patient can find its heading somewhere in that list.

The article types match the scope. Alongside original research, the journal's own description names special features including rapid communication of important timely issues, workshops, interesting case reports, clinical and basic science review articles, guest editorials, letters to the editor, book reviews and historical articles in geriatrics and gerontology. The current issues bear this out: systematic reviews and perspectives appear beside original studies, and a single recent issue can move from a biomarker study in sarcopenia to a mortality analysis in palliative care, a deprescribing trial's effects on sleep and quality of life, and a perspective on why dementia patients fail to adhere to cognitive rehabilitation.

Publisher, editors and editorial practice

The journal belongs to the Turkish Academic Geriatrics Society — its aims page describes it as the society's journal, published in accordance with the society's independent, unbiased and double-blinded peer-review principles — and Galenos Publishing House is its publisher, the imprint whose name appears in the journal's DOI stem: articles carry DOIs of the form 10.4274/ejgg.galenos, as in 10.4274/ejgg.galenos.2025.2025-8-1. The journal site maintains an editorial board and an advisory board, with published pages on the roles and responsibilities of editors and on how editors are recruited — governance detail that many younger journals never publish. Its instructions to authors and its separate instructions for reviewers, together with a stated peer-review process page, set out the working method: external, double-blind review of submissions in English, published three times a year in April, August and December in electronic form.

On access and licensing, the journal is open access, and its articles carry the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 licence line — readers may share the work with attribution, for non-commercial purposes, without alterations. The journal maintains an article processing charges policy page among its journal policies; the amount of any charge could not be verified from the pages fetched for this profile, and authors should read the current APC page on ejgg.org before submitting rather than rely on any third-party figure. The same caution applies to the journal's abstracting and indexing page, which the society maintains on the site: the verified position from sources fetched for this profile is set out in the indexing section below.

Metrics and standing

This journal displays its headline metrics on its own pages, and they are the natural starting point: the journal site gives a current Clarivate Impact Factor of 0.8 and a Scopus CiteScore of 0.8. SCImago-based listings for the title give an SJR of 0.177 and a best quartile of Q4 in Geriatrics and Gerontology, the quartile carried in this record's stored indicators; the stored record also gives an h-index of 7. OpenAlex, resolved through its ISSN endpoint to source S4210235367 at the time of checking, records 234 works, 428 citations, an h-index of 8 and a two-year mean citedness of about 0.68, with the journal's strongest topic cluster in frailty in older adults; OpenAlex also records the journal in Türkiye's national TR Dizin list. Read together, these figures describe a young society journal in its first decade: modest citation averages, an established place in the Scopus and Web of Science ecosystems, and a rising output — exactly the profile of a title whose value to an author lies in a defined specialty audience, a fast society-journal route to publication, and full open access visibility rather than in citation prestige.

Indexing and access

The verified indexing position is as follows. The journal is covered by Scopus, which its displayed CiteScore presupposes and which SCImago's Scopus-based listing confirms; it holds a Clarivate Journal Impact Factor, displayed on its own site; and OpenAlex records its presence in TR Dizin, the Turkish national index. The Directory of Open Access Journals search API returned no record for the journal's ISSN when checked for this profile — a directory gap, not an access gap: the journal itself is fully open access, and every issue can be read in full, free of charge, on ejgg.org, where the current issue, the ahead-of-print stream and the archive back to the 2019 foundation are held with article PDFs under the CC BY-NC-ND licence.

How to submit

Submissions are made through the journal site, where the Instructions to Authors page is the governing document and the Submit Article route is carried on every page. Prepare the manuscript in English, in the article type the journal recognises — original research, review, case report, letter, perspective and the other forms its aims describe — and expect independent double-blind review: remove identifying material as the instructions direct, and be ready to answer reviewers on method, because the journal's published papers show a consistent editorial standard of ethics approval statements, informed consent reporting, authorship contribution statements and conflict-of-interest and funding disclosures at the end of each article. Geriatric-specific reporting matters here: age ranges, frailty and functional measures, comorbidity and medication counts are this readership's first questions about any cohort, and papers that state them plainly travel through review fastest. Check the current article processing charges page before submitting, confirm the licence and copyright forms the publisher requires — the site carries its copyright agreement and permission request forms openly — and write the abstract for the clinician reader the journal's mission names: practical, timely and relevant.

Inside an issue: the journal at work

The August 2026 issue, current on the journal site as this profile was prepared, is a fair specimen of the journal's mix. Its original research opens with an immature granulocyte percentage study as a potential biomarker in post-menopausal sarcopenia; a tandem-stance mortality study in middle-aged and older adults; a triglyceride-glucose and biological ageing acceleration analysis built on the American NHANES surveys; a study showing frailty sharpening prognosis beyond a standard pneumonia score in community-acquired pneumonia; a score study in prefrailty and frailty; a polypharmacy-reduction study tracking sleep, anxiety and quality of life; a thirty-day mortality study in older adults with resistant bloodstream infections; a nutrition-goals and refeeding syndrome study; calf circumference as a prognostic sign in palliative care; and primitive reflexes and falls in older adults without neurodegenerative disease. A systematic review of gamified exercise for older women's physical health and a perspective on cognitive rehabilitation adherence in dementia close the number. Biomarkers, big survey data, ward-level prognosis, deprescribing, palliative care, falls and rehabilitation adherence — that is the scope list of the aims page, enacted in a single issue, and it is the best evidence of what the journal is for.

Earlier content shows the same range with a Turkish health-system thread running through it: a national report on healthcare problems and solutions for older adults in Türkiye, built with the country's public health and chronic disease institutes and a study group drawn from ministries, universities and professional associations, gave the journal a policy document of record, while its clinical papers move between Ankara cohorts and international collaborations without changing register. A society journal that can carry its own country's geriatric policy debate and an NHANES analysis in the same volume has found its niche.

Reading EJGG well: audience, evidence and fit

Three reading notes will help a directory user get the most from this journal. First, read it as a clinician's journal. Its mission sentence promises practical, timely and relevant information for physicians and researchers in practice, and its contents honour that promise: prognostic scores tested at the bedside, deprescribing outcomes a ward team can apply, falls and reflexes examined as clinical signs, palliative prognostication measured in calf circumference and inflammatory ratios. A basic-science paper is welcome here — biogerontology and cell biology are in the scope — but it is read by people who will ask what it changes for an older patient, and the journal's best papers answer that question themselves. Second, notice the journal's double address. It is a Turkish society's journal, and its Turkish health-system content — the national geriatrics report, the awareness study, the Ankara cohorts — is part of its value, giving English-language readers a documented window on a large, fast-ageing health system they would otherwise need Turkish to enter. At the same time its author base is international, and a Brazilian dietary-index study, a Danish fistula case report, Iranian trial reports and American survey analyses appear in its pages without any sense of being guests. Third, judge fit by the scope list and the current issue together: the aims page tells you what the journal says it wants, and the August 2026 contents tell you what it actually took — biomarkers with clinical cohorts behind them, scores validated against hard outcomes, and interventions measured on sleep, function and quality of life rather than on surrogates alone.

For librarians, the cataloguing facts are simple and should be kept exact: one electronic ISSN, 2687-2625; title in full as given here; society, the Turkish Academic Geriatrics Society; publisher, Galenos; place, Türkiye; start, April 2019; frequency, three issues a year; language, English; licence, CC BY-NC-ND 4.0. Because at least three other journals in the world carry near-identical names — an Egyptian journal of geriatrics and gerontology, an Italian journal of gerontology and geriatrics, and a Brazilian journal of geriatrics and gerontology in Portuguese — the ISSN, not the title, is the only safe way to route a reader, a citation or a subscription question to this journal, and this profile has been written so that every claim in it hangs on that identifier.

Related journals

EJGG's closest Turkish neighbour is the Turkish Journal of Geriatrics (Türk Geriatri Dergisi), the longer-running journal of the Turkish Geriatrics Society — a different society and a different title, with its own ISSNs, which readers should not confuse with this one. Within Türkiye, Geriatrik Bilimler Dergisi, the Journal of Geriatric Science, covers neighbouring ground. Internationally, the natural companions are the field's established society titles: Age and Ageing for the British Geriatrics Society, the Journal of the American Geriatrics Society, Geriatrics and Gerontology International for the Japan Geriatrics Society, and the European Geriatric Medicine journal serving the European geriatric medicine society — the European-level title whose existence explains why EJGG's own European name should be read as an address to a continent-wide readership rather than as the organ of a European society, which it is not. On JournalsWorld, EJGG's neighbours are the geriatrics and ageing titles in the medicine listings, where the single ISSN 2687-2625 anchors this record among many similarly named titles.

Frequently asked questions

What is the ISSN of the European Journal of Geriatrics and Gerontology?

It has a single electronic ISSN, 2687-2625, printed on the journal site and confirmed in the OpenAlex source record. There is no separate print ISSN.

Who publishes the European Journal of Geriatrics and Gerontology?

It is the journal of the Turkish Academic Geriatrics Society, published by Galenos Publishing House in Türkiye. The numeric publisher code in this record's earlier template text was a placeholder.

When was EJGG founded?

April 2019, according to the journal site's own journal information.

Is EJGG open access?

Yes. It is an open access journal; its articles are published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 licence and can be read in full on ejgg.org.

How is EJGG reviewed?

By independent, unbiased, double-blind peer review, in the journal's own words — external reviewers, anonymised on both sides.

How often does EJGG appear, and in what language?

Three times a year — April, August and December — electronically, and in English.

What are EJGG's impact metrics?

The journal site displays a Clarivate Impact Factor of 0.8 and a Scopus CiteScore of 0.8. OpenAlex records 234 works, 428 citations and an h-index of 8 at the time of checking; SCImago-based listings give SJR 0.177, quartile Q4 in Geriatrics and Gerontology.

What subjects does EJGG cover?

The full map of ageing medicine and science: frailty, sarcopenia, falls, dementia, delirium, polypharmacy, orthogeriatrics, palliative care, geriatric syndromes and subspecialties, the biology and demography of ageing, gerontechnology, long-term care and healthy ageing.

Does EJGG charge to publish?

The journal maintains an article processing charges policy page; the amount could not be verified from the pages fetched for this profile, so check the current policy on ejgg.org before submitting.